![Minnesota Partnership [Logo]](/images/menu-back2b.gif)
Minnesota Partnership Targets Aphids
From medical research to crop protection
Medical scientists in Minnesota are focusing their expertise on a pest that destroys soybeans. The goal of the Minnesota Partnership team is to develop an insecticide that is safe for humans but will kill the soybean aphid, a bug that's been ravaging Minnesota crops.
Minnesota Partnership Awards Over $5 Million in Research Grants
Focus includes cancer, heart disease, nanotechnology
The Minnesota Partnership for Biotechnology and Medical Genomics is awarding nearly $5.4 million in state–funded research support to six research teams. This new round of scientific exploration will provide initial support for research on cancer, neurological diseases, heart disease, gastrointestinal conditions and nanotechnology that could impact a range of diseases.
Minnesota Partnership Recruits Two Top Researchers
Two more nationally regarded researchers have been recruited to support critical biomedical research in Minnesota, thanks to the Minnesota Partnership for Biotechnology and Medical Genomics. The two faculty investigators have assumed their new positions at Mayo Clinic and the University of Minnesota.
Minnesota Partnership Announces Four Infrastructure Awards
$7 million in support of biomedical research
The Minnesota Partnership for Biotechnology and Medical Genomics is awarding $7 million in state-funded infrastructure support to four partnering research teams. The awards will provide equipment and materials for research on congenital heart disease, improved bioinformatics to analyze genomic data, advanced imaging of the brain for numerous diseases and the creation of a crystallization facility to study hundreds of medical conditions at the molecular level.
Minnesota Partnership Advances Potential MS Therapy
Clinical-stage manufacturing progressing at Biovest in Minneapolis
A production laboratory founded by the Minnesota Partnership has transferred its first potential therapy — a medication for multiple sclerosis — to a processing plant in Minnesota. This step will complete purification of material to fully enable translation from preclinical to clinical development.
An Economic Engine to Save Lives
Learn more about how the Minnesota
Partnership is working for you.
Latest News
Minnesota Partnership Funds Mobile Obesity Lab, Genetic Technology
The Minnesota Partnership is helping scientists bring obesity research to the people of the state. An obesity research "laboratory on wheels" — complete with the latest equipment — is one of two groundbreaking infrastructure projects recently awarded. The other is state-of-the-art technology to advance genomic studies with zebrafish, a highly versatile animal model for studying genetic aspects of cancer and many other fatal diseases.
Minnesota Partnership RFA for Infrastructure
The Minnesota Partnership is asking Mayo and University of Minnesota researchers for applications for new research infrastructure grants. Requests for up to $2 million will be considered. The deadline for applications is March 12. As with other Partnership awards, these applications must involve co-principal investigators from each institution and represent a mutual need that neither institution could meet independently.
Minnesota Partnership requests new research proposals. Funding could total $5 million.
Investigators at Mayo Clinic and the University of Minnesota are eligible to apply as Partnership teams for these research awards. Preference will be given to applications in the areas of heart disease, diabetes/obesity, and neurodegenerative disease.
|
|